Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation

Author： Leen Ann M   Tripic Tamara   Rooney Cliona M  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.10, Iss.3, 2010-03, pp. : 337-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infusion of Endothelial Progenitor Cells Accelerates Hematopoietic and Immune Reconstitution, and Ameliorates the Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation

By Zeng Lingyu  

Cell Biochemistry and Biophysics, Vol. 64, Iss. 3, 2012-12 ,pp. : 213-222

Humana Press, Inc

Access to resources Recommend Favorite

Autologous haemopoietic stem cell transplantation for autoimmune diseases

By Zeher Margit   Papp Gabor   Szodoray Peter  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 9, 2011-09 ,pp. : 1193-1201

Informa Healthcare

Access to resources Recommend Favorite

Allogeneic hematopoietic cell transplantation for renal cell carcinoma: ten years after

By Tykodi Scott S   Sandmaier Brenda M   Warren Edus H   Thompson John A  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 763-773

Informa Healthcare

Access to resources Recommend Favorite

Rituximab in hematopoietic cell transplantation

By Arai Sally   Miklos David B  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 6, 2010-06 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

T cell-based therapies for EBV-associated malignancies

By Taylor Graham S  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 1, 2004-01 ,pp. : 11-21

Informa Healthcare

Access to resources Recommend Favorite